Paediatric Emergencies During the COVID-19 Pandemic

María Isabel Lázaro Carreño1, Ana Barrés Fernández1, Diannet Quintero García1

  • 1Universitat de València, Valencia, Spain.

Global Pediatric Health
|February 24, 2021
PubMed

Insights

During the COVID-19 pandemic, Spanish emergency departments saw an 84.5% decrease in pediatric visits. Fear of contagion and lifestyle changes likely contributed to fewer, less urgent visits.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The Coronavirus Disease-19 (COVID-19) pandemic prompted government-mandated lockdowns and restructuring of healthcare services.
  • Emergency Departments (EDs) implemented new protocols, including pre-triage stations and separate circuits for suspected COVID-19 cases.

Purpose of the Study:

  • To analyze the impact of the COVID-19 state of alarm on pediatric emergency department visits in Spain.
  • To evaluate changes in patient volume, urgency levels, and the characteristics of children presenting with suspected COVID-19.

Main Methods:

  • Retrospective analysis of pediatric ED visits before and during the COVID-19 state of alarm.
  • Implementation of a pre-triage system with distinct pathways for suspected and non-suspected COVID-19 cases.
  • Categorization of patients based on symptoms like fever and respiratory issues.

Main Results:

  • A significant 84.5% reduction in overall pediatric ED visits was observed during the alarm state.
  • No increase in the severity or urgency of presented cases.
  • 40.97% of pediatric patients were classified as suspected COVID-19 cases.
  • Distinct patient profiles emerged between suspected and non-suspected COVID-19 groups based on symptoms.

Conclusions:

  • The COVID-19 lockdown and associated public behavior significantly altered pediatric emergency care utilization.
  • Parental fear of contagion likely deterred non-essential visits, redirecting cases to primary care or self-resolution.
  • EDs successfully adapted with new triage systems to manage the pandemic's impact on pediatric services.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
100
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
99
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89